一、本期业绩预计情况 （一）业绩预告期间 2025年1月1日至2025年9月30日 （二）业绩预告情况 证券代码：002044 证券简称：美年健康 公告编号：2025-075 美年大健康产业控股股份有限公司 2025年前三季度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 二、与会计师事务所沟通情况 本次业绩预告相关财务数据未经过注册会计师审计。 三、业绩变动原因说明 1、进入第三季度体检旺季，公司积极推动增收促检工作，整体订单签定与 客单价保持稳定，重点客户签单占比与到检份额有所提升，继续以客户全旅程管 理推动团个检的转化、复购与裂变；2、公司坚持 AI 与数字化赋能，在上半年提 效降本取得一定进展的基础上，持续秉持"多元增收、科学降本"，坚定实施科学 精准的降本增效措施，继续以"差异化产品力与极致服务体验"发力专项体检与检 后健康管理，打造医疗、营销、管理一体化的精益运营体系，巩固"专业检查-深 度服务-科学定制-持续复购"正向循环，迎接第四季度体检旺季，持续推动公司经 营高质量发展。 四、其他相关说明 预计的经营业绩：预计净利润为正值且属于同向 ...

Market Overview - On October 15, the AI medical sector rose by 2.05%, with Saili Medical leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Stock Performance - Saili Medical (603716) closed at 26.86, up 7.31% with a trading volume of 384,800 shares and a transaction value of 1.02 billion [1] - Meinian Health (002044) closed at 5.43, up 4.42% with a trading volume of 1,534,300 shares and a transaction value of 823 million [1] - Hongbo Pharmaceutical (301230) closed at 33.40, up 3.99% with a trading volume of 33,500 shares and a transaction value of 111 million [1] - Other notable stocks include Electric Science Digital (600850) up 3.79% and Yao Stone Technology (300725) up 3.45% [1] Capital Flow - The AI medical sector saw a net inflow of 189 million from institutional investors, while retail investors experienced a net outflow of 78.98 million [2][3] - Meinian Health had a net inflow of 88.56 million from institutional investors, but a net outflow of 93.20 million from retail investors [3] - Saili Medical also experienced a net inflow of 71.52 million from institutional investors, with retail investors withdrawing 32.95 million [3]

Group 1 - The core viewpoint of the news is that Meinian Health has seen a stock price increase of 5%, reaching 5.46 CNY per share, with a total market capitalization of 21.372 billion CNY [1] - Meinian Health's main business involves health check-ups and health management, with 95.67% of its revenue coming from health check-up services and 4.33% from other services [1] Group 2 - According to data, a fund under Xingzheng Global Fund has heavily invested in Meinian Health, with the Xingquan CSI 800 Six-Month Holding Index Enhanced A fund increasing its holdings by 6.478 million shares, totaling 13.3889 million shares, which constitutes 5.88% of the fund's net value [2] - The Xingquan CSI 800 Six-Month Holding Index Enhanced A fund has a current scale of 1.02 billion CNY and has achieved a year-to-date return of 13.02% [2] - The fund manager, Shen Qing, has a tenure of nearly 15 years, with the best fund return during this period being 164.92% [3]

Group 1 - The core viewpoint of the news is that Meinian Health has seen a stock price increase of 5%, reaching 5.46 CNY per share, with a total market capitalization of 21.372 billion CNY [1] - Meinian Health's main business involves health check-ups and health management, with 95.67% of its revenue coming from check-up services and 4.33% from other services [1] - The company is located in Shanghai and was established on January 22, 1991, with its listing date on May 18, 2005 [1] Group 2 - According to data from the top ten holdings of funds, Guotai Fund has a significant position in Meinian Health, with its Guotai Health Stock A fund reducing its holdings by 2.6955 million shares, now holding 4.9332 million shares, which constitutes 7.29% of the fund's net value [2] - The Guotai Health Stock A fund has a total scale of 330 million CNY and has achieved a year-to-date return of 6.74% [2] - The fund manager, Xu Zhibiao, has been in position for over 10 years, with the fund's best return during his tenure being 158% [3]

Core Points - The company announced the election of Mr. Xu Tao as the employee representative director of the ninth board of directors during the employee representative assembly held on October 14, 2025 [2] Summary by Category - **Company Announcement** - The company held an employee representative assembly on October 14, 2025, where Mr. Xu Tao was elected as the employee representative director [2]

北京商报讯（记者 王寅浩 实习记者 宋雨盈）10月14日，美年健康发布公告称，因工作需要，徐涛申请 辞去公司第九届董事会非职工代表董事及董事会下属战略委员会、提名委员会委员职务。辞职后，徐涛 将继续在公司担任总裁职务，并将在公司职工代表大会选举其为职工代表董事后履行相关职责。 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-073 美年大健康产业控股股份有限公司 二、职工代表董事选举情况 根据《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深圳证券 交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法律法规、 规范性文件以及《公司章程》的有关规定，公司于 2025 年 10 月 14 日召开了职工 代表大会，经全体与会职工代表表决，选举徐涛先生担任公司第九届董事会职工 代表董事，与经公司股东大会选举产生的第九届董事会非职工代表董事共同组成 公司第九届董事会，任期自本次职工代表大会选举通过之日起至公司第九届董事 会任期届满之日止。 徐涛先生当选职工代表董事后，公司第九届董事会中兼任公司高级管理人员 以及由职工代表担任的董事人数总计未超过公司董事总数的二分之一，符合相关 法律法规的要求。 三、董事会专门委员会委员选举情况 关于董事调整暨选举职工代表董事的公告 2025 年 10 月 14 日，公司召开第九届董事会第十四次（临时）会议，经全体 董事审议，一致同意选举徐涛先生担任公司第九届董事会下属战略委员会、提名 委员会委员职务，任期自本次董事会审议 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-072 美年大健康产业控股股份有限公司 2025 年第二次临时股东大会决议公告 1、会议召开的时间 （1）现场会议召开时间：2025 年 10 月 14 日（星期二）下午 14:50 （2）网络投票时间为：2025 年 10 月 14 日（星期二）9:15-15:00 1）通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 10 月 14 日 9:15-9:25，9:30-11:30 和 13:00-15:00； 2）通过互联网投票系统进行网络投票的具体时间为 2025 年 10 月 14 日 9:15-15:00 的任意时间。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决或修改提案的情况，无涉及变更前次股东大会决议的 情况。 2、本次股东大会审议的全部议案已对中小投资者（指除上市公司的董事、监 事、高级管理人员以及单独或者合计持有上市公司5%以上股份的股东以外的股东） 的表决单独计票。 一、会议召开和出席情况 （一）会议召开情况 2、现场会议召 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-074 美年大健康产业控股股份有限公司 二、董事会会议审议情况 第九届董事会第十四次（临时）会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 美年大健康产业控股股份有限公司（以下简称"公司"）第九届董事会第十四 次（临时）会议于 2025 年 9 月 28 日以电子发送等形式发出会议通知，会议于 2025 年 10 月 14 日下午 17 时以书面审议方式召开。应出席本次会议的董事为 9 名，实 际出席会议的董事为 9 名。本次会议的出席人数、召开表决程序、议事内容均符 合《中华人民共和国公司法》《公司章程》等有关规定。 1、审议并通过《关于选举代表公司执行公司事务的董事的议案》 表决结果：赞成 9 票，反对 0 票，弃权 0 票。 2、审议并通过《关于选举董事会各专门委员会成员及召集人的议案》 根据《中华人民共和国公司法》及《公司章程》等有关规定，同意公司选举 董事长俞熔先生为代表公司执行公司事务的董事，并担任法定代表人，任期自本 次董事会审议通过之日起至第九 ...

Group 1 - The core point of the article is that Meien Health announced the convening of its 14th temporary meeting of the 9th Board of Directors on October 14, 2025, to review various proposals, including the election of directors to manage company affairs [1] - For the first half of 2025, Meien Health's revenue composition shows that the medical industry accounted for 99.37% of total revenue, while other businesses contributed 0.63% [1] - As of the time of reporting, Meien Health has a market capitalization of 20.4 billion yuan [1]